Sign in
Join
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Monday, July 13, 2026
Sign in / Join
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Facebook
Instagram
Twitter
Vimeo
Youtube
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Search
Tags
EMA
Tag:
EMA
Healthcare
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
BFN's Desk
-
January 25, 2025
0
Insurance-Tips
Moving Averages Updates: HDFC Life Stock Price Breaks Above 20-Day EMA, Reaches Rs 586.75
BFN's Desk
-
February 28, 2024
0
Automobile
EMA Recommends Arpraziquantel for Treatment of Schistosomiasis in Preschool-Aged Children
BFN's Desk
-
December 18, 2023
0
Entertainment
Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe
BFN's Desk
-
February 16, 2023
0
Technology
New Research from EMA and NS1 Reveals Widespread Network
BFN's Desk
-
December 8, 2022
0
Entertainment
EMA Aesthetics signs agreement with 4ocean to become 'plastics impartial'.
BFN's Desk
-
November 7, 2022
0
Entertainment
Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib
BFN's Desk
-
October 28, 2022
0
Uncategorized
CSL Vifor and Travere Therapeutics announce EMA has accepted for review the Conditional Marketing Authorization application for sparsentan for the treatment of IgA Nephropathy
BFN's Desk
-
August 22, 2022
0
Most Read
Made-in-India Skoda Kylaq Completes 19,351-km Pune-to-Prague Drive Across 13 Countries
July 10, 2026
Sahyadri Super Specialty Hospital performs autologous stem cell transplant
July 10, 2026
XECH launches SteamX Fold hybrid garment steamer
July 10, 2026
OPPO India launches Reno16 Series with AI features
July 10, 2026